Drug therapies are the bedrock of cancer care. Making these therapies affordable, while continuing to encourage innovation of new treatments, is crucial to accomplishing the mission of the American Cancer Society Cancer Action Network (ACS CAN) to end cancer as we know it, for everyone. ACS CAN has long fought for public policies that support both the affordability and availability of medically necessary prescription drugs.
Congress and the Administration are moving forward with proposals to address drug pricing, from the enactment of the Inflation Reduction Act (IRA) to newly released Executive Orders (EOs). This paper provides an overview of some of these prescription drug pricing proposals and the potential impact on cancer care.
